Frequencies of hla-a24 and hla-dr4-dq8 are increased and that of hla-b blank is decreased in chronic toxic oil syndrome

International Journal of Immunogenetics

Volumn 23, Issue 3, 1996, Pages 211-219

  Arnaiz Villena, A ^a   Martinez Laso, J ^a   Corell, A ^a   Allende, L ^a   Rosal, M ^a   Gomez Reino, J J ^b   Vicario, J L ^c  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c Department of Histocompatibility ^*  (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA DQ ANTIGEN; HLA DR4 ANTIGEN;

ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HISTOCOMPATIBILITY GENE; HLA TYPING; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TOXIC OIL SYNDROME;

FEMALE; GENE FREQUENCY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-DQ ANTIGENS; HLA-DR4 ANTIGEN; HUMANS; PLANT OILS; POISONING;

EID: 0029934529     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/j.1744-313X.1996.tb00116.x     Document Type: Article

References (36)

1. Arnaiz-Villena, A., Rodriguez de Cordoba, S., Vela, F., Pascual, J.C., Cervero, J. & Bootello, A. (1981) HLA antigens in a sample of the Spanish population: common features among Spaniards, Basques and Sardinians. Human Genetics, 58, 344.
2. Arnaiz-Villena, A., Vicario, J.L., San Andres, F. & Serrano-Rios, M. (1984) Fase crónica de la enfermedad por ingestión de aceite de colza tóxico: un nuevo sindrome asociado a HLA. Inmunologia, 3, 151.
3. Auffray, C., Lillie, J.W., Arnot, D., Grossberger, D., Kappes, D. & Strominger, J.L. (1984) Isotypic and allotypic variation of human class II histocompatibility antigen α-DQ chain genes. Nature, 308, 227.
4. Batchelor, J.R., Welsh, K.I., Mansilla-Tinoco, R., Dollery, C.T., Hughes, G.R.V., Ryan, Bernstein, R., Naish, P.F., Aber, G.M., Bing, R.F. & Russel, G.I. (1980) Hydralazine induced systemic lupus erythematosus: influence of HLA-DR and sex susceptibility. Lancet, i, 1107.
5. Baur, M.P. & Danilovs, J.A. (1980) Population analysis of HLA-A, B, C, DR and other genetic markers. In: Histocompatibility Testing 1980 (ed. by P. Terasaki), pp. 955. UCLA Tissue Typing Laboratory, Los Angeles, CA.
6. Bidwell, J. (1988) DNA-RFLP analysis and genotyping of HLA-DR and DQ antigens. Immunology Today, 1, 18.
7. Bidwell, J. & Jarrod, E. (1986) HLA-DR allogenotyping using exon-specific cDNA probes and application of rapid minigel methods. Molecular Immunology, 10, 1111.
8. Bodmer, J.G., Marsh, S.G.E., Albert E.D., Bodmer, W.F., Dupont, B., Erlich, H.A., Mach, B., Mayr, W.R., Parham, Sasazuki, T., Schreuder, G.M. Th, Strominger, J.L., Svejgaard, A. & Terasaki, P.I. (1992) Nomenclature for factors of the HLA system, 1991. Tissue Antigens, 39, 161.
9. Bodmer, J.G., Marsh, S.G.E., Albert, E.D., Bodmer, W.F., Dupont B., Erlich, H.A., Mach, B., Mayr, W.R., Parham, Sasazuki, T., Schreuder, G.M. Th., Strominger, J.L., Svejgaard, A. & Terasaki, P.I. (1994) Nomenclature for factors of the HLA system, 1994. Tissue Antigens, 44, 1.
10. Breur-Vriesendorp, B.S., Vingerhoed, J., Schaasberg, W.P. & Ivanyi, P. (1990) Variations in the T-cell repertoire against HLA antigens in humans. Human Immunology, 27, 1.
11. Briggs, D., Black, C. & Welsh, K. (1990) Genetic factors in Scleroderma. Rheumatic Diseases and Clinics of North America, 16, 31.
12. Clements, P.J., Opelz, G., Terasaki, P.I., Michey, M.R. & Furst, D. (1978) Association of HLA antigen A9 with progressive systemic sclerosis (scleroderma). Tissue Antigens, 11, 357.
13. Danilovs, J., Terasaki, P.I., Park, M.S. & Ayoub, G. (1980) B lymphocyte isolation by thrombin-nylon wood. In: Histocompatibility Testing 1980 (ed. by P.I. Terasaki), pp. 287. UCLA Tissue Typing Laboratory, Los Angeles, CA.
14. De Vries, R.R.P., Meerakhan, Bernini, L.F., Van Loghem, E. & Van Rood, J.J. (1979) Genetic control of survival in epidemics. Journal of Immunogenetics, 6, 271.
15. Ercilla, M.G., Arriahes, F. & Gratacos, M.R. (1981) HLA antigens and scleroderma. Archives of Dermatological Research, 271, 381.
16. Fondo de Investigaciones Sanitarias (1990) Toxic Oil Syndrome's Reference: Archivo del Ministerio de Sanidad y Consumo, Spain.
17. Gershon, D. (1990) Tryptophan under suspicion. Nature, 346, 787.
18. Gutierrez, C., Gaspar L., Muro, R., Kreisler, H. & Ferriz, P. (1983) Autoimmunity in patients with Spanish Toxic Oil Syndrome. Lancet, i, 644.
19. Hill, A.V.S., Allsopp, C.E.M., Kwiatkowski, D., Anstey, N., Twumasi, Rowe, P.A., Bennett, S., Brewster, D.R., McMichael, A.J. & Greenwood, B.M. (1991) Common West African HLA alleles are associated with protection from severe malaria. Nature, 352, 595.
20. Klein, J. (1991) Of HLA, trys, and selection: an essay on coevolution of MHC and parasites. Human Immunology, 30, 247.
21. Lahoz, C., Tricas, L., Vela, C., Lauzurica, Gurbindo, C. & Garcia, R. (1983) Hyper IgE, eosinophilia and immunological hyper-reactivity due to ingestion of adulterated rapeseed oil (Toxic Oil Syndrome). European Journal of Respiratory Diseases 64, (Suppl 126), 415.
22. Larharmar, D., Schanning, L., Gustafson, K., Claesson, L., Rask, L. & Peterson, P.A. (1982) Complete aminoacid sequence of an HLA-DR antigen-like β-chain as predicted from the nucleotide sequence. Similarities with immunoglobulins and HLA-A, -B, -C antigens. Proceedings of the National Academy of Science USA 79, 3687.
23. Luderschmidt, C., Schulz, S., Mehlhalf, E., Koning, G. & Albert, E. (1987) Association of progressive systemic scleroderma to several HLA-B and HLA-DR alleles. Archives of Dermatology, 123, 1188.
24. Martinez-Laso, J., Vicario, J.L., Corell, A., Martin-Villa, J.M., Morales, Lledo, G. & Arnaiz-Villena, A. (1991) Exclusive HLA-DQ factors do not explain susceptibility to insulin-dependent diabetes. Human Immunology, 31, 134.
25. Martinez-Laso, J., De Juan, D., Martinez-Quiles, N., Gomez-Casado, E., Cuadrado, E. & Arnaiz-Villena, A. (1995) The contribution of the HLA-A, -B, -C and -DR, -DQ DNA typing to the study of the origins of Spaniards and Basques. Tissue Antigens, 45, 237.
26. Parham, P. & Lawlor, D.A. (1991) Evolution of class I MHC genes and molecules in human and apes. Human Immunology, 30, 119.
27. Rabin, B.S., Rodnan, G.P., Bassions, S. & Gill, T.J. (1975) HLA antigens in progressive systemic sclerosis (scleroderma). Arthritis and Rheumatism, 18, 381.
28. Rigopuolou, D., Martinez-Laso, J., Martinez-Tello, F., Alcaide, J.F., Benmamar, D., Hawkins F. & Arnaiz-Villena, A. (1994) Both HLA class I and class II HLA antigens are thyroid cancer susceptibility factors. Tissue Antigens, 43, 281.
29. Segurado, O.G., Iglesias-Casarrubios, Vicario, J.L., Coreli, A., Regueiro, J.R. & Arnaiz-Villena, A. (1990) Shared SstI RFLPs by HLA-Aw19, A23/24 and A3/11 crosssreacting groups. Tissue Antigens, 35, 206.
30. Shulman, E.L. (1990) The eosinophilia-myalgia syndrome associated with ingestion of L-Tryptophan. Arthritis and Rheumatism, 33, 913.
31. Vicario, J.L., Serrano-Rios, M., San Andres, F. & Arnaiz-Villena, A. (1982) HLA-DR3, DR4 increase in chronic stage of Spanish oil disease. Lancet, i, 98.
32. Vicario, J.L., Martinez-Laso, J., Gomez-Reino, J.J., Gomez-Reino, F.J., Regueiro, J.R., Corell, A., Segurado, O.G. & Arnaiz-Villena, A. (1990) Both HLA class II and class III DNA polymorphisms are linked to Juvenile Rheumatoid Arthritis susceptibility. Clinical Immunology and Immunopathology, 56, 22.
33. Vicario, J.L., Martinez-Laso, J., Corell, A., Martin-Villa, J.M., Morales, Lledo, G., Segurado, O.G., De Juan, M.D. & Arnaiz-Villena, A. (1992) Comparison between HLA-DRB and DQ DNA sequences and classic serological markers as Type I (insulin-dependent) diabetes mellitus predictive risk markers in the Spanish population. Diabetologia, 35, 475.
34. Watkins, D.I., Chen, Z.W., Hughes, A.L., Evans, M.G., Tedder, T.F. & Letvin, N.L. (1990) Evolution of the MHC class I genes of a new world primate from ancestral homologies of human non-classical genes. Nature, 346, 60.
35. World Health Organization (1984) Toxic Oil Syndrome mass food poisoning in Spain. WHO Regional Office for Europe, Copenhagen.
36. World Health Organization (1990) Toxic Oil Syndrome mass food poisoning in Spain. WHO Regional Office for Europe, Copenhagen.